Carcinoembryonic Antigen as a Predictor of Pathologic Response and a Prognostic Factor in Locally Advanced Rectal Cancer Patients Treated With Preoperative Chemoradiotherapy and Surgery

International Journal of Radiation Oncology Biology Physics

Volumn 74, Issue 3, 2009, Pages 810-817

  Park, Ji Won ^a   Lim, Seok Byung ^a,b   Kim, Dae Yong ^a   Jung, Kyung Hae ^a,b   Hong, Yong Sang ^a   Chang, Hee Jin ^a   Choi, Hyo Seong ^a   Jeong, Seung Yong ^a  

^a National Cancer Center   (South Korea)

^b University of Ulsan College of Medicine   (South Korea)

Author keywords

Carcinoembryonic antigen; Neoadjuvant therapy; Rectal neoplasms; Rectal surgery

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; CHEMORADIOTHERAPY; CLINICAL VALUE; DISEASE FREE SURVIVAL; NEOADJUVANT THERAPY; PATHOLOGIC RESPONSE; PROGNOSTIC FACTORS; RECTAL CANCER; RECTAL NEOPLASMS; RECTAL SURGERY; TUMOR REGRESSION GRADES;

ANTIGENS; BODY FLUIDS; PATIENT MONITORING; SURGERY; TELEVISION PICTURE TUBES; TUMORS;

FLUORESCENT SCREENS;

CAPECITABINE; CARCINOEMBRYONIC ANTIGEN; FLUOROURACIL; FOLINIC ACID; IRINOTECAN;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER GRADING; CANCER RADIOTHERAPY; CANCER REGRESSION; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; PREOPERATIVE CARE; PRIORITY JOURNAL; PROGNOSIS; RECTUM CARCINOMA; RECTUM RESECTION; TREATMENT RESPONSE;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; CARCINOEMBRYONIC ANTIGEN; COMBINED MODALITY THERAPY; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; PROGNOSIS; RECTAL NEOPLASMS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 67349185928     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2008.08.057     Document Type: Article

References (30)

1. Kapiteijn E., Marijnen C.A.M., Nagtegaal I.D., et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med 345 (2001) 638-646
2. Sauer R., Becker H., Hohenberger W., et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 351 (2004) 1731-1740
3. Rodel C., Martus P., Papadoupolos T., et al. Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer. J Clin Oncol 23 (2005) 8688-8696
4. Kim D.W., Lim S.B., Kim D.Y., et al. Pre-operative chemo-radiotherapy improves the sphincter preservation rate in patients with rectal cancer located within 3 cm of the anal verge. Eur J Surg Oncol 32 (2006) 162-167
5. Bosset J.F., Collette L., Calais G., et al. Chemotherapy with preoperative radiotherapy in rectal cancer. N Engl J Med 355 (2006) 1114-1123
6. Gerard J.P., Conroy T., Bonnetain F., et al. Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers: Results of FFCD 9203. J Clin Oncol 24 (2006) 4620-4625
7. Locker G.Y., Hamilton S., Harris J., et al. ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer. J Clin Oncol 24 (2006) 5313-5327
8. Berman J.M., Cheung R.J., and Weinberg D.S. Surveillance after colorectal cancer resection. Lancet 355 (2000) 395-399
9. Das P., Skibber J.M., Rodriguez-Bigas M.A., et al. Predictors of tumor response and downstaging in patients who receive preoperative chemoradiation for rectal cancer. Cancer 109 (2007) 1750-1755
10. Park Y.A., Sohn S.K., Seong J., et al. Serum CEA as a predictor for the response to preoperative chemoradiation in rectal cancer. J Surg Oncol 93 (2006) 145-150
11. Yoon S.M., Kim D.Y., Kim T.H., et al. Clinical parameters predicting pathologic tumor response after preoperative chemoradiotherapy for rectal cancer. Int J Radiat Oncol Biol Phys 69 (2007) 1167-1172
12. Larsen S.G., Wiig J.N., Dueland S., et al. Prognostic factors after preoperative irradiation and surgery for locally advanced rectal cancer. Eur J Surg Oncol 34 (2008) 410-417
13. Kim Y.H., Kim D.Y., Kim T.H., et al. Usefulness of magnetic resonance volumetric evaluation in predicting response to preoperative concurrent chemoradiotherapy in patients with resectable rectal cancer. Int J Radiat Oncol Biol Phys 62 (2005) 761-768
14. Dworak O., Keilholz L., and Hoffmann A. Pathological features of rectal cancer after preoperative radiochemotherapy. Int J Colorectal Dis 12 (1997) 19-23
15. In: Greene F.L., Page D.L., Fleming I.D., et al. (Eds). American Joint Committee on Cancer Staging Manual. 6th ed. (2002), Springer, Philadelphia
16. Quirke P., Dixon M.F., Durdey P., et al. Local recurrence of rectal adenocarcinoma due to inadequate surgical resection: Histopathological study of lateral tumor spread and surgical excision. Lancet 2 (1986) 996-999
17. Kim D.Y., Jung K.H., Kim T.H., et al. Comparison of 5-fluorouracil/leucovorin and capecitabine in preoperative chemoradiotherapy for locally advanced rectal cancer. Int J Radiat Oncol Biol Phys 67 (2007) 378-384
18. Youden W.J. Index for rating diagnostic tests. Cancer 3 (1950) 32-35
19. Ghadimi B.M., Grade M., Difilippantonio M.J., et al. Effectiveness of gene expression profiling for response prediction of rectal adenocarcinomas to preoperative chemoradiotherapy. J Clin Oncol 23 (2005) 1826-1838
20. Smith F.M., Reynolds J.V., Miller N., et al. Pathological and molecular predictors of the response of rectal cancer to neoadjuvant radiochemotherapy. Eur J Surg Oncol 32 (2006) 55-64
21. Benchimol S., Fuks A., Jothy S., et al. Carcinoembryonic antigen, a human tumor marker, functions as an intercellular adhesion molecule. Cell 57 (1989) 327-334
22. Hammarstrom S. The carcinoembryonic antigen (CEA) family: Structures, suggested functions and expression in normal and malignant tissues. Semin Cancer Biol 9 (1999) 67-81
23. Ordonez C., Screaton R.A., Ilantzis C., et al. Human carcinoembryonic antigen functions as a general inhibitor of anoikis. Cancer Res 60 (2000) 3419-3424
24. Riesterer O., Milas L., and Ang K.K. Use of molecular biomarkers for predicting the response to radiotherapy with or without chemotherapy. J Clin Oncol 25 (2007) 4075-4083
25. Cascini G.L., Avallone A., Delrio P., et al. 18F-FDG PET is an early predictor of pathologic tumor response to preoperative radiochemotherapy in locally advanced rectal cancer. J Nucl Med 47 (2006) 1241-1248
26. Kim N.K., Baik S.H., Seong J.S., et al. Oncologic outcomes after neoadjuvant chemoradiation followed by curative resection with tumor-specific mesorectal excision for fixed locally advanced rectal cancer: Impact of postirradiated pathologic downstaging on local recurrence and survival. Ann Surg 244 (2006) 1024-1030
27. Das P, Skibber JM, Rodriguez-Bigas MA, et al. Clinical and pathologic predictors of locoregional recurrence, distant metastasis, and overall survival in patients treated with chemoradiation and mesorectal excision for rectal cancer. Am J Clin Oncol 21006;29:219-224.
28. Kuo L.J., Liu M.C., Jian J.J., et al. Is final TNM staging a predictor for survival in locally advanced rectal cancer after preoperative chemoradiation therapy?. Ann Surg Oncol 14 (2007) 2766-2772
29. Bouzourene H., Bosman F.T., Matter M., et al. Predictive factors in locally advanced rectal cancer treated with preoperative hyperfractionated and accelerated radiotherapy. Hum Pathol 34 (2003) 541-548
30. Mawdsley S., Glynne-Jones R., Grainger J., et al. Can histopathologic assessment of circumferential margin after preoperative pelvic chemoradiotherapy for T3-T4 rectal cancer predict for 3-year disease-free survival?. Int J Radiat Oncol Biol Phys 63 (2005) 745-752